Trial · NCT03420781
Participant flow35
How many started, completed or left each group, period by period.
21 to 35 of 35
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| RW Period: 6 Weeks (Week 41 to Week 46) | STARTED | Treatment Period: Placebo | 0 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | STARTED | Treatment Period: Relamorelin 10 μg | 0 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | STARTED | Randomized Withdrawal Period: Placebo Then Relamorelin 10 μg | 91 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | STARTED | Randomized Withdrawal Period: Relamorelin 10 μg Then Relamorelin 10 μg | 59 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | STARTED | Randomized Withdrawal Period: Relamorelin 10 μg Then Placebo | 43 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | COMPLETED | Treatment Period: Placebo | 0 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | COMPLETED | Treatment Period: Relamorelin 10 μg | 0 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | COMPLETED | Randomized Withdrawal Period: Placebo Then Relamorelin 10 μg | 85 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | COMPLETED | Randomized Withdrawal Period: Relamorelin 10 μg Then Relamorelin 10 μg | 54 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | COMPLETED | Randomized Withdrawal Period: Relamorelin 10 μg Then Placebo | 38 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | NOT COMPLETED | Treatment Period: Placebo | 0 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | NOT COMPLETED | Treatment Period: Relamorelin 10 μg | 0 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | NOT COMPLETED | Randomized Withdrawal Period: Placebo Then Relamorelin 10 μg | 6 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | NOT COMPLETED | Randomized Withdrawal Period: Relamorelin 10 μg Then Relamorelin 10 μg | 5 | |
| RW Period: 6 Weeks (Week 41 to Week 46) | NOT COMPLETED | Randomized Withdrawal Period: Relamorelin 10 μg Then Placebo | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03420781/flow?page=2